Prenetics Winds Down Bitcoin Strategy to Back David Beckham-Linked IM8

The health sciences company said its board has approved an update to its capital allocation strategy, formally halting further Bitcoin acquisitions. While the company will retain its existing digital asset holdings, it will no longer deploy additional funds into cryptocurrency purchases, marking a shift away from a treasury approach it only recently adopted.

Prenetics Global Limited confirmed that it ceased its daily Bitcoin buying program on December 4, 2025. The company currently holds 510 Bitcoin, which it intends to keep on its balance sheet as a reserve asset. However, management made clear that Bitcoin will no longer play an active role in capital deployment decisions going forward.

IM8 was launched in partnership with former professional footballer David Beckham, whose involvement has helped elevate the brand’s global profile. Since launch, Prenetics has leaned into a premium positioning strategy, targeting consumers seeking science-backed, simplified health solutions. The company believes this approach differentiates IM8 in a crowded supplements market and supports its ambitious revenue outlook.

Instead, Prenetics is redirecting financial resources toward accelerating the growth of IM8, its consumer health and wellness brand launched in late 2024. The company said the move reflects a reassessment of where capital can generate the greatest long-term value, particularly as IM8 continues to gain traction at a pace that has exceeded internal expectations.

IM8 has emerged as a central pillar of Prenetics’ business strategy over the past year. The brand’s flagship product, IM8 Daily Ultimate Essentials, is positioned as an all-in-one nutritional supplement designed to simplify daily health routines. Prenetics said IM8 surpassed $100 million in annualized recurring revenue within 11 months of launch, a milestone the company describes as unprecedented within the supplements industry.

On the back of that momentum, Prenetics is now forecasting IM8 revenue of between $180 million and $200 million for the 2026 fiscal year. Management said future capital will be directed toward product development, brand building, global expansion initiatives and the recruitment of senior talent to support the brand’s next phase of growth.

The company also highlighted its financial position in outlining the strategic change. Prenetics reported more than $70 million in cash and cash equivalents and no outstanding debt, giving it flexibility to fund expansion plans without reliance on external financing. Against that backdrop, the board concluded that deploying capital into IM8 offered a clearer path to sustainable shareholder value than continuing to accumulate Bitcoin.

Prenetics’ decision comes amid a broader conversation around the role of digital assets in corporate treasury strategies. Over recent years, a number of publicly listed companies have adopted Bitcoin as a reserve asset, citing its long-term appreciation potential and hedge characteristics. However, Prenetics’ move underscores how those strategies remain subject to revision as business priorities evolve.

The company emphasized that the change does not represent a rejection of Bitcoin as an asset class. By retaining its existing holdings, Prenetics signaled that it continues to view Bitcoin as a long-term store of value. At the same time, the company said it no longer sees incremental Bitcoin purchases as the best use of capital relative to reinvesting directly into its operating business.

Danny Yeung, CEO and Co-Founder of Prenetics, said, "The phenomenal success of IM8 has exceeded all expectations and scaled much faster than our original expectations. Our Board and management team unanimously agreed that the most promising path to creating significant, sustainable shareholder value is to devote our undivided attention to this once-in-a-generation opportunity clearly visible in IM8. We are incredibly excited about the future of IM8 and are confident that by focusing our efforts, we can propel its growth to even greater heights. Operating from a position of strength, we are making disciplined strategic decisions that reflect our experience as operators and our commitment to maximizing long-term shareholder value."

The capital allocation update also illustrates a wider shift in how some companies are balancing exposure to emerging asset classes against reinvestment in core operations. While digital assets remain a part of the corporate finance conversation, Prenetics’ decision highlights the opportunity cost considerations boards face when allocating capital in fast-moving markets.

Prenetics said it plans to continue expanding IM8’s geographic footprint, deepen distribution channels and invest in consumer engagement initiatives. Product innovation will also remain a focus, as the company seeks to build out a broader portfolio under the IM8 brand.

The development clarifies Prenetics’ near-term priorities and places IM8 firmly at the center of its growth narrative. With a strengthened balance sheet and a single-brand focus, the company is positioning itself to capitalize on what it views as a defining opportunity in the consumer health sector.